Cargando…
Revisiting Regulators of Human β-cell Mass to Achieve β-cell–centric Approach Toward Type 2 Diabetes
Type 2 diabetes (T2DM) is characterized by insulin resistance and β-cell dysfunction. Because patients with T2DM have inadequate β-cell mass (BCM) and β-cell dysfunction worsens glycemic control and makes treatment difficult, therapeutic strategies to preserve and restore BCM are needed. In rodent m...
Autores principales: | Sasaki, Hironobu, Saisho, Yoshifumi, Inaishi, Jun, Itoh, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361804/ https://www.ncbi.nlm.nih.gov/pubmed/34405128 http://dx.doi.org/10.1210/jendso/bvab128 |
Ejemplares similares
-
Effects of Obesity and Diabetes on α- and β-Cell Mass in Surgically Resected Human Pancreas
por: Inaishi, Jun, et al.
Publicado: (2016) -
Ethnic Similarities and Differences in the Relationship between Beta Cell Mass and Diabetes
por: Inaishi, Jun, et al.
Publicado: (2017) -
Associations of birthweight and history of childhood obesity with beta cell mass in Japanese adults
por: Sasaki, Hironobu, et al.
Publicado: (2020) -
Beta-Cell Mass in Obesity and Type 2 Diabetes, and Its Relation to Pancreas Fat: A Mini-Review
por: Inaishi, Jun, et al.
Publicado: (2020) -
Changes in glycemic variability, gastric emptying and vascular endothelial function after switching from twice-daily to once-weekly exenatide in patients with type 2 diabetes: a subpopulation analysis of the twin-exenatide study
por: Inaishi, Jun, et al.
Publicado: (2022)